Mandatory disclosure of holding and notice of trade in IDEX Biometrics - 23 July 2025

23 Jul 2025 11:50 CEST

Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a
private placement of 9,090,909 shares at NOK 3.30 per share. IDEX discloses the
following information on behalf of a major shareholder and primary insider.

Tranche 1 of the private placement amounted to 4,731,594 shares. As disclosed
separately, Pinchcliffe AS, a company closely related to CEO and CFO Anders
Storbråten, participated in the private placement and subscribed for 739,360
shares in Tranche 1.

In connection with the private placement, the manager of the private placement,
IDEX Biometrics and Mr. Storbråten entered into a share lending agreement.

Mr. Storbråten has lent 4,731,594 shares, ISIN NO0013536078, in connection with
the settlement of Tranche 1. The shares have been lent, not sold, and will be
returned in due course.

After the subscription by Pinchcliffe and the temporary lending of shares, Mr.
Storbråten and close relations hold 6,503,476 or 12,48% shares of the total
outstanding shares and votes in IDEX Biometrics after completion of Tranche 1.

Contact person
Anders Storbråten, CEO and CFO
Tel: +47 4163 8582
E-mail: ir@idexbiometrics.com

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint
biometrics, offering authentication solutions across payments, access control,
and digital identity. Our solutions bring convenience, security, peace of mind
and seamless user experiences to the world. Built on patented and proprietary
sensor technologies, integrated circuit designs, and software, our biometric
solutions target card-based applications for payments and digital
authentication. As an industry-enabler we partner with leading card
manufacturers and technology companies to bring our solutions to market.

For more information, visit www.idexbiometrics.com

About this notice
This notice was issued by Erling Svela, Vice president of finance, on 23 July
2025 at 11:50 CET on behalf of IDEX Biometrics ASA. The information about the
lending shall be disclosed according to article 19 no. 3 of the EU Market Abuse
Regulation (EU 596/2014). The information about shareholding shall be disclosed
according to section 4-2 of the Norwegian Securities Trading Act (STA). The
information is published in accordance with section 5?12 of the Norwegian
Securities Trading Act.

More information:
Access the news on Oslo Bors NewsWeb site